March 29, 2017 11:00 AM ET

Pharmaceuticals

Company Overview of Valens Pharma Ltd.

Company Overview

Valens Pharma Ltd., a biopharmaceutical company, focuses on commercializing drug product candidates in the class of energy metabolism agents, referred to as PDK blockers. Its technology is focused on metabolic modulation, through the use of dichloroacetate (DCA) and related compounds. The company’s DCA i.v. product in the PDK Blocker platform includes earlier stage compounds that target the treatment of cardiovascular disease, as well as related metabolic conditions, such as diabetes. Valens Pharma Ltd. was formerly known as CardioMetabolics, Inc. The company was founded in 2000 and is based in Edmonton, Canada.

8308 114 Street NW

Edmonton, AB T6G 2E1

Canada

Founded in 2000

Phone:

780-438-2818

Fax:

780-438-2874

Key Executives for Valens Pharma Ltd.

Chief Executive Officer and President
Age: 52
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
4everPets Ltd. Americas
9037136 Canada Inc. Americas
AAA Heidelberg Inc. Americas
Ab Biotech Inc. Americas
AB Laboratories Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Valens Pharma Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.